Related Experiment Video
Updated: May 5, 2026
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Characterization of pathological stages in a mouse model of progressive multiple sclerosis
Satoshi Hamano1, Toshiki Yoshimizu1, Mutsuki Mori1
1Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan.
Abstract:
The purpose of this study was to analyze and elucidate the mechanisms of non-obese diabetes-experimental autoimmune encephalomyelitis (NOD-EAE), an animal model of progressive multiple sclerosis (MS), and to compare the pathological features with those observed in human progressive MS. Pathological analysis, flow cytometry analysis, immunohistochemical staining, and transcriptome analysis were performed at each pathological stage of the NOD-EAE mice to characterize each pathological stage in the lesion. The NOD-EAE mice showed a biphasic pattern of disease progression once in remission. The longitudinal profile of demyelination and inflammatory cell infiltration in the spinal cord was consistent with the pathological score. In the chronic phase of the disease, fibrosis and lymph follicle formation, characteristic of progressive human MS, were observed. Here we describe the pathological profile and transcriptome analysis of the NOD-EAE mice and verify that this model has similar features to those of human progressive MS. Our findings suggest that this model recapitulates lymph follicle formation, a disease hallmark of progressive MS, and fibrosis, a feature complicating the pathogenesis of MS in the chronic phase. This model may be useful for evaluating the efficacy of therapeutic agents and for mechanistic analysis.
Insights
The non-obese diabetes-experimental autoimmune encephalomyelitis (NOD-EAE) mouse model effectively mimics progressive multiple sclerosis (MS) pathology, including fibrosis and lymph follicle formation. This model aids in understanding MS mechanisms and testing new therapies.
Area of Science:
- Neuroimmunology
- Pathology
- Animal Models
Background:
- Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
- Progressive forms of MS lack adequate animal models that recapitulate key pathological features.
- Understanding the mechanisms of progressive MS is crucial for developing effective treatments.
Purpose of the Study:
- To analyze and elucidate the mechanisms of the non-obese diabetes-experimental autoimmune encephalomyelitis (NOD-EAE) mouse model.
- To compare the pathological features of NOD-EAE with human progressive multiple sclerosis (MS).
- To validate the NOD-EAE model for studying MS pathogenesis and therapeutic efficacy.
Main Methods:
- Pathological analysis of NOD-EAE mice at various disease stages.
- Flow cytometry and immunohistochemical staining for immune cell characterization.
- Transcriptome analysis to identify molecular changes during disease progression.
- Longitudinal monitoring of demyelination and inflammation in the spinal cord.
Main Results:
- NOD-EAE mice exhibited a biphasic disease progression pattern.
- Demyelination and inflammatory cell infiltration correlated with pathological scores.
- Chronic phase NOD-EAE showed fibrosis and lymph follicle formation, mirroring human progressive MS.
- Transcriptome analysis provided insights into disease-specific molecular pathways.
Conclusions:
- The NOD-EAE mouse model accurately recapitulates key pathological hallmarks of human progressive MS.
- Fibrosis and lymph follicle formation in this model offer opportunities for mechanistic studies.
- The NOD-EAE model serves as a valuable platform for evaluating therapeutic strategies for progressive MS.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
